The clinical imperative to treat maternal hyperthermia with acetaminophen is complicated by emerging evidence of the drug’s association with neurodevelopmental disorders. This article examines this risk-benefit challenge and proposes a shift toward a more nuanced, indication-specific prescribing paradigm in pregnancy.
Darayesh et al. (Wed,) studied this question.